22 February 2016
: Case report
Marjolin’s Ulcer Complicating a Pressure Sore: The Clock is Ticking
Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Kamran KhanCDEF, Anna Lucia GiannoneCDEF, Erfan MehrabiF, Ayda KhanF, Roberto E. GiannoneEDOI: 10.12659/AJCR.896352
Am J Case Rep 2016; 17:111-114
Abstract
BACKGROUND: Malignant degeneration in any chronic wound is termed a Marjolin’s ulcer (MU). The overall metastatic rate of MU is approximately 27.5%. However, the prognosis of MU specific to pressure sores is poor, with a reported metastatic rate of 61%. This is due to insidious, asymptomatic malignant degeneration, a lack of healthcare provider awareness, and, ultimately, delayed management.
CASE REPORT: An 85-year-old white male was noted by his wound-care nurse to have a rapidly developing growth on his lower back over a period of 4 months. There was history of a non-healing, progressive pressure ulcer of the lower back for the past 10 years. On examination, there was a 4×4 cm pressure ulcer of the lower back, with a superimposed 1.5×2 cm growth in the superior region. There was an absence of palpable regional lymphadenopathy. Punch biopsy revealed squamous cell carcinoma consistent with Marjolin’s ulcer. The ulcer underwent excision with wide margins, and a skin graft was placed. Due to the prompt recognition of an abnormality by the patient’s wound-care nurse, metastasis was not evident on imaging. There are no signs of recurrence at 1-year follow-up.
CONCLUSIONS: Marjolin’s ulcer has a rapid progression from local disease to widespread metastasis. Therefore, it is essential that wound-care providers are aware of the clinical signs and symptoms of malignant degeneration in chronic wounds.
Keywords: Carcinoma, Squamous Cell - surgery, Aged, 80 and over, Lumbosacral Region, Pressure Ulcer - complications, Skin Neoplasms - surgery, Surgical Flaps
SARS-CoV-2/COVID-19
31 January 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937955
18 January 2023 : Case report
Am J Case Rep 2023; 24:e938667
30 December 2022 : Case report
Am J Case Rep 2022; 23:e938571
22 December 2022 : Case report
Am J Case Rep 2022; 23:e938003
In Press
01 Feb 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938498
31 Jan 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937955
31 Jan 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938889
27 Jan 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938548
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399